JPS52156900A - Process for preparing 9*100dihydroergocine and physiologically acceptable acid additives thereof and application as medicine - Google Patents

Process for preparing 9*100dihydroergocine and physiologically acceptable acid additives thereof and application as medicine

Info

Publication number
JPS52156900A
JPS52156900A JP2290077A JP2290077A JPS52156900A JP S52156900 A JPS52156900 A JP S52156900A JP 2290077 A JP2290077 A JP 2290077A JP 2290077 A JP2290077 A JP 2290077A JP S52156900 A JPS52156900 A JP S52156900A
Authority
JP
Japan
Prior art keywords
medicine
preparing
application
physiologically acceptable
acceptable acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2290077A
Other languages
Japanese (ja)
Inventor
Rukuman Rudorufu
Deiorujiebitsuku Neboisa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals and Chemical Co dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals and Chemical Co dd filed Critical Lek Pharmaceuticals and Chemical Co dd
Publication of JPS52156900A publication Critical patent/JPS52156900A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2290077A 1976-03-04 1977-03-04 Process for preparing 9*100dihydroergocine and physiologically acceptable acid additives thereof and application as medicine Pending JPS52156900A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU545/76A YU40275B (en) 1976-03-04 1976-03-04 Process for preparing 9,10-dihydro-ergosine and physiologically tolerated acid addition salts thereof

Publications (1)

Publication Number Publication Date
JPS52156900A true JPS52156900A (en) 1977-12-27

Family

ID=25550399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2290077A Pending JPS52156900A (en) 1976-03-04 1977-03-04 Process for preparing 9*100dihydroergocine and physiologically acceptable acid additives thereof and application as medicine

Country Status (11)

Country Link
JP (1) JPS52156900A (en)
AT (1) AT352301B (en)
BE (1) BE851961A (en)
CS (1) CS200506B2 (en)
DD (1) DD128612A5 (en)
DE (1) DE2708042A1 (en)
FR (1) FR2342979A1 (en)
HU (1) HU173239B (en)
NL (1) NL7702332A (en)
SE (1) SE7702254L (en)
YU (1) YU40275B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016187522A1 (en) * 2015-05-20 2016-11-24 Noramco, Inc. Process for the preparation of oxymorphone freebase

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE669619A (en) * 1961-05-10 1966-03-14

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1216213A (en) * 1954-12-03 1960-04-22 Cilag Spa Process for the preparation of dihydrogenated compounds of synthetic or natural derivatives of lysergic acid
CH602765A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE669619A (en) * 1961-05-10 1966-03-14

Also Published As

Publication number Publication date
HU173239B (en) 1979-03-28
FR2342979B1 (en) 1980-10-03
AT352301B (en) 1979-09-10
YU54576A (en) 1983-01-21
NL7702332A (en) 1977-09-06
DD128612A5 (en) 1977-11-30
YU40275B (en) 1985-12-31
ATA134577A (en) 1979-02-15
FR2342979A1 (en) 1977-09-30
BE851961A (en) 1977-07-01
CS200506B2 (en) 1980-09-15
SE7702254L (en) 1977-09-05
DE2708042A1 (en) 1977-09-08

Similar Documents

Publication Publication Date Title
JPS52122632A (en) Medical composition and process for preparing same
NZ183222A (en) Azetidine pyrrolidine-orpiperidine-2-carboxylic acid derivatives and pharmaceutical compositions
JPS5392752A (en) Novel 11betaasubstituted 4*99dienesteroid derivative process for preparing same and pharmaceutical composition
JPS52116492A (en) Alkyloxim derivative of novel 77aminothiazolylacetamide cephalospolanate process for preparing same and medical composition
GR61176B (en) Pharmaceutical compositions and process for the preparation thereof
JPS5379873A (en) 22position substituted 1*44dihydropyridine derivative* method for its production and its use as drug
GB2011900A (en) N'-substituted -aminoalkanoyl- -aminoalkanoic acids their use and process for their production as well as pharmaceutical products containing these compounds
ATA387777A (en) Process for the preparation of the novel 17,18- dehydroapovincaminol and its acid addition salts
JPS5390254A (en) Novel 11betaasubstituted 1*3*5*10**trienesteroid process for preparing same and pharmaceutical composition
GR63213B (en) 4-trifluormethylbenzoic acid derivatives and process of making the same and pharmaceutical compositions containing thereof
GB2043644B (en) 3-phosphonocephalosporanic acid derivatives process for preparation thereof and pharmaceutical composition comprising the same
IL52466A (en) 7(2-acyl-2-hydroxyiminoacetamido)-3-tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
GB1543004A (en) 7-aminothiazolylacetamido-cephalosporanic acid derivatives processes for preparing them and pharmaceutical compositions containing them
DE2964101D1 (en) Penam-3-carboxylic acid 1,1-dioxides, process for their preparation and pharmaceutical compositions
ZA784471B (en) Derivatives of 1,3-diphenoxypropane-2-on,process for their preparation,medicaments thereof,and their use as medicaments
HU173881B (en) Process for producing n-bracket-1h-benzimidazol-2-yl-bracket closed-carbamates and pharmaceutical compositions containing them as active agents
JPS5318526A (en) Phenoxyyalkanone acid derivatives*process for preparation thereof and composition containing same
JPS5259161A (en) 1*44dihydroo2*66dimethyll44 phenyll3*55pyridineedicarbonic acid isobuthylmethyl preparation method and medicine thereof
GB1538705A (en) 1,4-dihydropyridine-sugar derivatives process for their preparation and their use as medicaments
EP0000633A3 (en) 2,5 -disubstituted-3-substituted methyl-penta-2,4-dienoic acid and derivatives, process for their preparation and their use in the preparation of alpha-substituted-thien-3-yl acetic acid and derivatives
PT67483B (en) Process for preparing new octahydro-indolo/2,3-a/ quinolisines and pharmaceutical compositions thereof
JPS52136156A (en) Production of novel 177 spirosultine derivatives and corresponding gammaa hydroxylic acid and pharmaceutical composition
JPS52156900A (en) Process for preparing 9*100dihydroergocine and physiologically acceptable acid additives thereof and application as medicine
JPS53130682A (en) Novel 11*33*3*4*55trimethoxyphenoxy**22 hydroxyypropyl**44aryllpiperazine derivative process for preparing same and medicine containing same
JPS5473769A (en) *22oxoopyrrolidinee1** and *22oxoopiperidinee 1**carboxylic acid derivatives*their manufacture and medical composition containing them